Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S. (Reuters) ...

The US Food and Drug Administration (FDA) today issued a letter to healthcare providers describing a current shortage of Getinge intra-aortic balloon pump (IABP) catheters and other components.

WAYNE, N.J., May 25, 2018 /CNW/ -- Getinge, a leading global provider of innovative medical technology, today announced results from the Survival Improvement in Extensive Myocardial Infarction with ...

The US Food and Drug Administration (FDA) has urged healthcare providers not to use certain Getinge devices amid concerns that the company’s devices still pose a risk to users despite a previous ...

Getinge AB reported that intraortic balloon pumps (IABPs) manufactured by its Datascope subsidiary are in short supply following a recall of some of these devices in 2019. Getinge said manufacturing ...

Vancouver, British Columbia (June 9, 2021) - iData Research, a global consulting and market research firm, has released exclusive research on the ventricular assist and intra-aortic balloon pump ...

May 8 (Reuters) - The U.S Food and Drug Administration (FDA) on Wednesday advised healthcare facilities to move away from using Getinge's heart devices in patients as they faced safety and quality ...

(Reuters) -The U.S Food and Drug Administration (FDA) on Wednesday advised healthcare facilities to move away from using Getinge's heart devices in patients as they faced safety and quality concerns ...